New hope for managing diabetes in kids with rare blood disorder

This study tested whether a newer type of diabetes drug (a GLP-1 receptor agonist) works better than standard insulin therapy for children and teenagers with transfusion-dependent thalassemia who also have diabetes. The trial involved 80 participants aged 10-18 and compared how well the two treatments controlled blood sugar over six months. The goal was to find a safer, more effective way to manage this common complication of their lifelong blood disorder.